Literature DB >> 16338389

Assays for high-throughput screening of E2 AND E3 ubiquitin ligases.

John H Kenten1, Ilia V Davydov, Yassamin J Safiran, David H Stewart, Pankaj Oberoi, Hans A Biebuyck.   

Abstract

We developed a series of assays for biochemical activities involving ubiquitin. These assays use electrochemiluminescence detection to measure the ubiquitylation of target proteins. To enable electrochemiluminescence detection, the target proteins were prepared as bacterially expressed fusion proteins and captured on the surface of specially designed microtiter plates having integrated electrodes. Ubiquitylation was quantitated directly, through the use of ubiquitin labeled with an electrochemiluminescent label, or indirectly, through the use of labeled antiubiquitin antibodies. Assays were carried out in both 96-well and 384-well plates. The success of the assay with this variety of formats allowed the selection of optimal work flows for specific applications on the basis of ease of use and overall reagent consumption and availability. We used our ubiquitylation assays to measure the activities of E2 ubiquitin-conjugating enzymes and E3 class ubiquitin ligases. Signal/background ratios for many of our assays were greater than 50, significantly facilitating their conversion to high-throughput practice in a convenient manner. The speed, sensitivity, and convenience of the assay formats makes them well suited for comprehensive interrogations of libraries of compounds or genes in applications like drug and substrate discovery for ubiquitin ligases.

Mesh:

Substances:

Year:  2005        PMID: 16338389     DOI: 10.1016/S0076-6879(05)99045-9

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  5 in total

1.  Inhibition of Siah2 ubiquitin ligase by vitamin K3 (menadione) attenuates hypoxia and MAPK signaling and blocks melanoma tumorigenesis.

Authors:  Meera Shah; John L Stebbins; Antimone Dewing; Jianfei Qi; Maurizio Pellecchia; Ze'ev A Ronai
Journal:  Pigment Cell Melanoma Res       Date:  2009-08-27       Impact factor: 4.693

Review 2.  The Next Frontier: Translational Development of Ubiquitination, SUMOylation, and NEDDylation in Cancer.

Authors:  Nicole E Pellegrino; Arcan Guven; Kayleigh Gray; Punit Shah; Gargi Kasture; Maria-Dorothea Nastke; Anjan Thakurta; Stephane Gesta; Vivek K Vishnudas; Niven R Narain; Michael A Kiebish
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

3.  Photocleavage-based affinity purification of biomarkers from serum: Application to multiplex allergy testing.

Authors:  Zhi Wan; Heather P Ostendorff; Ziying Liu; Lynda C Schneider; Kenneth J Rothschild; Mark J Lim
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240

4.  A novel reporter for real-time, quantitative imaging of AKT-directed K63-poly-ubiquitination in living cells.

Authors:  Shyam Nyati; Nauman Chaudhry; Areeb Chatur; Brandon S Gregg; Lauren Kimmel; Dheeraj Khare; Venkatesha Basrur; Dipankar Ray; Alnawaz Rehemtulla
Journal:  Oncotarget       Date:  2018-01-25

5.  The MALDI-TOF E2/E3 Ligase Assay as Universal Tool for Drug Discovery in the Ubiquitin Pathway.

Authors:  Virginia De Cesare; Clare Johnson; Victoria Barlow; James Hastie; Axel Knebel; Matthias Trost
Journal:  Cell Chem Biol       Date:  2018-07-12       Impact factor: 8.116

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.